Studies on molecular mechanisms of Ginkgo biloba extract
- PMID: 14740187
- DOI: 10.1007/s00253-003-1527-9
Studies on molecular mechanisms of Ginkgo biloba extract
Abstract
In the past decade, interest by the general public in the use of herbal dietary supplements has risen exponentially. As throughout history, individuals are now turning to the use of "natural" therapies for the prevention, treatment and cure of almost every ailment and aging malady imaginable. often without substantial proof of safety or efficacy. One of the most popular herbal supplements is Ginkgo biloba extract, taken for its perceived "memory enhancing" properties. Given the inordinate popularity, growing use, and substantial number of pharmaceutical products containing G. biloba, coupled with demands for product safety and "hard evidence," science has followed this trend closely with an ever-expanding body of pharmacological and clinical data on such preparations. Claims that standardized G. biloba extract (EGb 761) can modulate the cellular environment of an organism under both physiological and stress conditions may be attributed to its multivalent or totipotent properties, and can now be substantiated by the availability of modern molecular techniques. As opposed to pharmacologically manufactured or synthetic drugs, which provide a single target for a single receptor as the mechanism of action, EGb 761 is able to up- or down-regulate signaling pathways, gene transcription, cellular metabolism, etc., and thus assist in the regulation of the general physiological status of the cell and/or organism in response to stressors posed by both intracellular and extracellular conditions. Presumably, this is one of the biggest advantages of using natural products for the prevention and treatment of infirmity, as well as the maintenance of health in an organism.
Copyright 2004 Springer-Verlag
Similar articles
-
Alzheimer's disease, the nematode Caenorhabditis elegans, and ginkgo biloba leaf extract.Life Sci. 2006 Mar 27;78(18):2066-72. doi: 10.1016/j.lfs.2005.12.004. Epub 2006 Feb 28. Life Sci. 2006. PMID: 16507312 Review.
-
Dual effects of Ginkgo biloba leaf extract on human red blood cells.Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):138-44. doi: 10.1111/j.1742-7843.2008.00354.x. Epub 2008 Dec 18. Basic Clin Pharmacol Toxicol. 2009. PMID: 19143753
-
Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence?Curr Alzheimer Res. 2007 Jul;4(3):253-62. doi: 10.2174/156720507781077304. Curr Alzheimer Res. 2007. PMID: 17627482 Review.
-
Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761.Cell Mol Biol (Noisy-le-grand). 2002 Sep;48(6):625-31. Cell Mol Biol (Noisy-le-grand). 2002. PMID: 12396072 Review.
-
A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.Hum Psychopharmacol. 2002 Aug;17(6):267-77. doi: 10.1002/hup.412. Hum Psychopharmacol. 2002. PMID: 12404671 Clinical Trial.
Cited by
-
Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders.Food Sci Biotechnol. 2024 Jul 10;33(13):2903-2917. doi: 10.1007/s10068-024-01656-3. eCollection 2024 Oct. Food Sci Biotechnol. 2024. PMID: 39234277 Review.
-
From traditional medicine to nanomedicine: potential of Ginkgo biloba extracts in treating inflammatory skin diseases.RSC Med Chem. 2024 Jun 11;15(8):2643-2656. doi: 10.1039/d4md00194j. eCollection 2024 Aug 14. RSC Med Chem. 2024. PMID: 39149101 Review.
-
Ginkgo biloba extract inhibits hippocampal neuronal injury caused by mitochondrial oxidative stress in a rat model of Alzheimer's disease.PLoS One. 2024 Aug 6;19(8):e0307735. doi: 10.1371/journal.pone.0307735. eCollection 2024. PLoS One. 2024. PMID: 39106233 Free PMC article.
-
MicroRNAs in Anticancer Drugs Hepatotoxicity: From Pathogenic Mechanism and Early Diagnosis to Therapeutic Targeting by Natural Products.Curr Pharm Biotechnol. 2024;25(14):1791-1806. doi: 10.2174/0113892010282155231222071903. Curr Pharm Biotechnol. 2024. PMID: 38178678 Review.
-
Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation.CNS Neurol Disord Drug Targets. 2024;23(10):1234-1250. doi: 10.2174/0118715273273539231114095300. CNS Neurol Disord Drug Targets. 2024. PMID: 38018200 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous